Trials / Completed
CompletedNCT03635333
Effects of E-Cigarette Flavors on Adults TCORS 2.0
Effects of E-Cigarette Flavors on Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This study looks at the effects of flavors when administered with nicotine in e-cigarettes in younger and older adult cigarette smokers.
Detailed description
This study looks at the effects of flavors when administered with nicotine in e-cigarettes in younger and older adult cigarette smokers. Regular cigarette smokers who do not want to quit smoking will be asked to complete 3 lab sessions in which they will use an e-cigarette and complete questionnaires. This will be followed by a two-week period where participants are asked to stop using cigarettes and other tobacco products and to only use the e-cigarettes provided. Researchers will examine the influence of flavors (sweet, cool, tobacco) on reward (liking/wanting) from e-cigs containing one of two nicotine concentrations (6 mg/ml, 18 mg/ml) following acute tobacco abstinence. As of October 2020, this protocol was updated in which an additional lab session was added. Participants are to complete 4 lab sessions in which they will use an e-cigarette and complete questionnaires. In each individual lab session, they will sample one of the following four e-liquids: cherry, vanilla, menthol, tobacco. Additionally, participant age range was shifted to 21-50 with the younger condition being 21-34 and older being 35-50 and cigarette requirement was at least 1 cigarette/day at this time to be more representative of current persons who smoke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicotine | Nicotine level (6 or 18 mg) |
| DRUG | Flavor | Flavor of e-juice (tobacco, menthol, cherry, vanilla) |
Timeline
- Start date
- 2019-05-14
- Primary completion
- 2023-07-12
- Completion
- 2023-07-12
- First posted
- 2018-08-17
- Last updated
- 2025-12-19
- Results posted
- 2025-12-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03635333. Inclusion in this directory is not an endorsement.